Logo

Sandoz Canada Congratulates the Quebec Government on Implementing a Shift Towards Biosimilars

Share this
Sandoz Canada Congratulates the Quebec Government on Implementing a Shift Towards Biosimilars

Sandoz Canada Congratulates the Quebec Government on Implementing a Shift Towards Biosimilars

Shots:

  • Quebec will follow a similar approach to policies introduced in British Columbia- Alberta and recently in New Brunswick to transition patients who use a reference biologic to a biosimilar. This will contribute to annual savings that can be reinvested in healthcare and innovative new drugs
  • The transition will take place under the supervision of the attending physicians & patients will continue receiving safe & effective treatment
  • Sandoz Canada is committed to supporting patients- their HCPs- and the Quebec government throughout the transition period with quality biosimilar medicines- medical teams- physician- and pharmacist advocacy teams- as well as with patient support programs

Ref: Sandoz| Image: Sandoz

Click here to­ read the full press release 

Tuba

Tuba Khan is Senior Editor at PharmaShots. She is curious, creative, and passionate about recent updates and innovation in the Life sciences industry. She covers Biopharma, MedTech, and Digital health segments. Tuba also has an experience of digital and social media marketing and runs the campaigns independently. She can be contacted on connect@pharmashots.com

Share this article on WhatsApp, LinkedIn and Twitter

Related News/Articles

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions